Provider [Proveedor]
QP102-23 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective February 1, 2024
Fecha de entrada en vigencia del programa: 13 de diciembre de 2023